MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

Home・Akcijų sąrašas・Rigel Pharmaceuticals Inc

Rigel Pharmaceuticals Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

18.8 -3.84

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

18.53

Max

19.05

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+68.27% upside

Dividendai
By Dow Jones
Kitas uždarbis	2025-08-05

Naujienos nuotaikos

By Acuity

50%

174 / 376 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

0.785 / 0.96 Palaikymas ir pasipriešinimas

Rigel Pharmaceuticals Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-07-11 22:19; UTC

Įsigijimai, susijungimai, perėmimai

FCC Approves U.S. Cellular Sale to T-Mobile

2025-07-11 17:28; UTC

Pagrindinės rinkos jėgos

SharpLink Gaming Gains on Ethereum Purchase

2025-07-11 16:57; UTC

Uždarbis

BASF Cuts Outlook on Global Economy Uncertainty

2025-07-11 21:45; UTC

Rinkos pokalbiai

Fitch Affirms Germany's Rating, Sees Deficit, Debt Rising -- Market Talk

2025-07-11 19:46; UTC

Įsigijimai, susijungimai, perėmimai

Kraft Heinz Might Split Up, Report Says. What Investors Need to Know. -- Barrons.com

2025-07-11 19:45; UTC

Rinkos pokalbiai

Crude Futures Post Back-to-Back Weekly Gains -- Market Talk

2025-07-11 19:05; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Post Third Straight Weekly Loss -- Market Talk

2025-07-11 18:18; UTC

Rinkos pokalbiai

Canada Officials Tight-Lipped on Next Steps in Trump Trade Talks -- Market Talk

2025-07-11 17:35; UTC

Rinkos pokalbiai

Canada Should Target Lower Sectoral Tariffs, Import Quotas in US Trade Talks -- Market Talk

2025-07-11 17:26; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Down by 1 to 424 -- Market Talk

2025-07-11 16:53; UTC

Rinkos pokalbiai

Crude Futures Add to Early Gains -- Market Talk

2025-07-11 16:42; UTC

Uždarbis

BASF Cuts Outlook on Global Economic Uncertainty

2025-07-11 16:08; UTC

Rinkos pokalbiai

Rise in Canadian Staycations May Help Explain Labor Market Strength -- Market Talk

2025-07-11 16:05; UTC

Uždarbis

BASF Will Publish Half-Year Results on July 30

2025-07-11 16:04; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-07-11 16:04; UTC

Rinkos pokalbiai

Senior Housing Shortage Gives REITs Pricing Power -- Market Talk

2025-07-11 16:03; UTC

Uždarbis

BASF: Guidance Cut Is Due to Ongoing Macroeconomic, Geopolitical Uncertainties

2025-07-11 16:02; UTC

Uždarbis

BASF Continues to Expect Free Cash Flow Between EUR400M and EUR800M in 2025

2025-07-11 16:01; UTC

Uždarbis

BASF Had Seen Ebitda Before Special Items Between EUR8B and EUR8.4B in 2025

2025-07-11 16:00; UTC

Uždarbis

BASF Now Sees Ebitda Before Special Items Between EUR7.3B and EUR7.7B in 2025

2025-07-11 15:59; UTC

Uždarbis

BASF Cuts 2025 Earnings View

2025-07-11 15:58; UTC

Uždarbis

Nvidia's CEO Has Sold a Million Shares. He Has Millions More to Sell. -- Barrons.com

2025-07-11 15:57; UTC

Uždarbis

BASF 2Q EBIT Before Special Items EUR810M

2025-07-11 15:54; UTC

Uždarbis

BASF: Analysts Had Expected 2Q Sales of EUR15.80B

2025-07-11 15:54; UTC

Uždarbis

BASF 2Q Sales Fell 2.1% on Year

2025-07-11 15:53; UTC

Uždarbis

BASF 2Q Sales EUR15.77B

2025-07-11 15:52; UTC

Uždarbis

BASF: This Was in Line With Consensus Estimates

2025-07-11 15:52; UTC

Uždarbis

BASF 2Q Ebitda Before Special Items EUR1.77B

2025-07-11 15:49; UTC

Uždarbis

BASF Reports Preliminary 2Q Figures, Adjusts 2025 Outlook

2025-07-11 15:41; UTC

Rinkos pokalbiai

Oil, Gas Prices Not Seen Supporting Drilling Boom -- Market Talk

Akcijų palyginimas

Kainos pokytis

Rigel Pharmaceuticals Inc Prognozė

Kainos tikslas

By TipRanks

68.27% į viršų

12 mėnesių prognozė

Vidutinis 32.98 USD 68.27%

Aukščiausias 57 USD

Žemiausias 20.45 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Rigel Pharmaceuticals Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

3 ratings

Pirkti

Laikyti

Parduoti

Remiantis 3 analitikų, pateikusių Rigel Pharmaceuticals Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

0.785 / 0.96Palaikymas ir pasipriešinimas

Recent bearish events outweigh bullish events.

Bearish events outweigh bullish events.

All events are bearish.

Rinkos nuotaikos

By Acuity

174 / 376 reitingas Sveikatos priežiūra

Finansinės naujienos

Kitos sektoriaus akcijos

MDT

Medtronic PLC

89.97

↑ +0.71%

VEEV

Veeva Systems Inc

275.84

↓-1.9%

Agilent Technologies Inc

123.3

↓-0.67%

WBA

Walgreens Boots Alliance Inc

11.51

↓-0.35%

HQY

HealthEquity Inc

94.45

↓-2.78%

Rigel Pharmaceuticals Inc

Apžvalga

Akcijų kainos pasikeitimas

Rekomendacijos

Dividendai

Naujienos nuotaikos

Techninis įvertinimas

Rigel Pharmaceuticals Inc Grafikas

Susijusios naujienos

Akcijų palyginimas

Rigel Pharmaceuticals Inc Prognozė

Kainos tikslas

Bendras įvertinimas

Techninis įvertinimas

Rinkos nuotaikos

Finansinės naujienos

Kitos sektoriaus akcijos